Product Information
NORETHINDRONE 0.35 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0924 per EA under NDC 68180087673. Its NADAC has been published 263 times since Sep 22, 2021.
FDA first approved this application on Sep 19, 2011. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.35 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180087673
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA091325FDA Approved
9/19/2011
TE Code
AB1
On Market Since
11/11/2020
Pharmacological Classes
Price Statistics
The NADAC for NORETHINDRONE 0.35 MG TABLET has been published 263 times since Sep 22, 2021, and over the history we have for it it has declined 48.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0924 per EA |
|---|---|
| All-time high | $0.1898 (Nov 10, 2021) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.1105 |
| Average price | $0.1181 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 263 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NORETHINDRONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORETHINDRONE 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORETHINDRONE 0.35 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0924 per EA (NDC 68180087673), effective Sep 30, 2026.
How has the price of NORETHINDRONE 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORETHINDRONE 0.35 MG TABLET has declined 48.1%. It has been tracked across 263 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for NORETHINDRONE 0.35 MG TABLET?
Since Sep 22, 2021, the NADAC for NORETHINDRONE 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.1898 (Nov 10, 2021), with a median of $0.1105 per EA.
Are there cheaper alternatives to NORETHINDRONE 0.35 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAMILA 0.35 MG TABLET, is $0.0906 per EA — about 2% below NORETHINDRONE 0.35 MG TABLET.
Who manufactures NORETHINDRONE 0.35 MG TABLET?
NORETHINDRONE 0.35 MG TABLET (NDC 68180087673) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.